Source link : https://www.newshealth.biz/health-news/high-strength-wegovy-aldosteronism-outcome-definitions-insulin-unit-price-down-42/
Patients treated with semaglutide 7.2 mg achieved a 20.7% weight loss after 72 weeks compared with a reduction of 17.5% with semaglutide 2.4 mg (Wegovy) and 2.4% with placebo, results from the phase IIIb STEP UP trial showed. Eli Lilly has its sights set on approval of orforglipron, a once-daily oral GLP-1 receptor agonist for […]
Author : News Health
Publish date : 2025-01-21 19:32:20
Copyright for syndicated content belongs to the linked Source.